How Ibrutinib Has Transformed the Treatment Paradigm of CLL

September 21, 2017
Javier Pinilla-Ibarz, MD, PhD

Javier Pinilla-Ibarz, MD, PhD, associate member, Malignant Hematology and Immunology Program at the H. Lee Moffitt Cancer Center, discusses how ibrutinib has transformed the treatment landscape of chronic lymphocytic leukemia.